EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Adverse cardiovascular events and cardiac imaging findings in patients on immune checkpoint inhibitors

Jennifer M Kwan, Miles Shen iD, Narjes Akhlaghi, Jiun-Ruey Hu, Ruben Mora, James L Cross iD, Matthew Jiang, Michael Mankbadi, Peter Wang, Saif Zaman, Seohyuk Lee, Yunju Im und 6 weitere

PLOS ONE · 2024

DOI: 10.1371/journal.pone.0314555 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Jennifer M Kwan und 17 weiteren Autor:innen. Beteiligte Einrichtung: Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, Connecticut, United States of America. Hauptthemen laut MEDLINE: Immune Checkpoint Inhibitors, Cardiovascular Diseases. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCATS NIH HHS, American Heart Association, National Center for Advancing Translational Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

There is an urgent need to better understand the diverse presentations, risk factors, and outcomes of immune checkpoint inhibitor (ICI)-associated cardiovascular toxicity. There remains a lack of consensus surrounding cardiovascular screening, risk stratification, and clinical decision-making in patients receiving ICIs.

Methods

We conducted a single center retrospective cohort study including 2165 cancer patients treated with ICIs between 2013 and 2020. The primary outcome was adverse cardiovascular events (ACE): a composite of myocardial infarction, coronary artery disease, stroke, peripheral vascular disease, arrhythmias, heart failure, valvular disease, pericardial disease, and myocarditis. Secondary outcomes included all-cause mortality and the individual components of ACE. We additionally conducted an imaging substudy examining imaging characteristics from echocardiography (echo) and cardiac magnetic resonance (CMR) imaging.

Results

In our cohort, 44% (n = 962/2165) of patients experienced ACE. In a multivariable analysis, dual ICI therapy (hazard ratio [HR] 1.23, confidence interval [CI] 1.04–1.45), age (HR 1.01, CI 1.00–1.01), male sex (HR 1.18, CI 1.02–1.36), prior arrhythmia (HR 1.22, CI 1.03–1.43), lung cancer (HR 1.17, CI 1.01–1.37), and central nervous system (CNS) malignancy (HR 1.23, CI 1.02–1.47), were independently associated with increased ACE. ACE was independently associated with a 2.7-fold increased risk of mortality ( P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immune Checkpoint InhibitorsCardiovascular DiseasesHumansMaleFemaleMiddle AgedAgedRetrospective StudiesEchocardiographyNeoplasmsRisk FactorsMagnetic Resonance Imaging

Substanzen

Immune Checkpoint Inhibitors

Autor:innen und Institutionen

  • Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, Connecticut, United States of America.
  • Yale University School of Medicine, New Haven, Connecticut, United States of America.
  • Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, United States of America.
  • Nuvance Health, Danbury, Connecticut, United States of America.
  • Department of Biostatistics, University of Nebraska Medical Center, Omaha, Nebraska, United States of America.
  • Department of Biostatistics, Yale University School of Public Health, New Haven, Connecticut, United States of America.

ORCID-Profile: Miles Shen, James L Cross, Lauren A Baldassarre

Förderung

  • NCATS NIH HHS
  • American Heart Association
  • National Center for Advancing Translational Sciences

Zitieren

APA

Kwan, J. M., Shen, M., Akhlaghi, N., Hu, J. R., Mora, R., Cross, J. L., Jiang, M., Mankbadi, M., Wang, P., Zaman, S., Lee, S., Im, Y., Feher, A., Liu, Y. H., Ma, S. S., Tao, W., Wei, W., & Baldassarre, L. A. (2024). Adverse cardiovascular events and cardiac imaging findings in patients on immune checkpoint inhibitors. PLOS ONE. https://doi.org/10.1371/journal.pone.0314555

Vancouver

Kwan JM, Shen M, Akhlaghi N, Hu JR, Mora R, Cross JL, et al. Adverse cardiovascular events and cardiac imaging findings in patients on immune checkpoint inhibitors. PLOS ONE. 2024. doi:10.1371/journal.pone.0314555

BibTeX
@article{Kwan2024,
  author = {Kwan, Jennifer M and Shen, Miles and Akhlaghi, Narjes and Hu, Jiun-Ruey and Mora, Ruben and Cross, James L and Jiang, Matthew and Mankbadi, Michael and Wang, Peter and Zaman, Saif and Lee, Seohyuk and Im, Yunju and Feher, Attila and Liu, Yi-Hwa and Ma, Shuangge S and Tao, Weiwei and Wei, Wei and Baldassarre, Lauren A},
  title = {Adverse cardiovascular events and cardiac imaging findings in patients on immune checkpoint inhibitors},
  journal = {PLOS ONE},
  year = {2024},
  doi = {10.1371/journal.pone.0314555}
}
Kostenlos starten →